These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18250143)

  • 1. Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; de Vos P; Bixel MG; Vestweber D; van Berkel TJ; Kuiper J
    Cardiovasc Res; 2008 Jun; 78(3):590-6. PubMed ID: 18250143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against TIE2 reduces atherosclerosis.
    Hauer AD; Habets KL; van Wanrooij EJ; de Vos P; Krueger J; Reisfeld RA; van Berkel TJ; Kuiper J
    Atherosclerosis; 2009 Jun; 204(2):365-71. PubMed ID: 19022447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
    Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
    Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
    Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.
    Hauer AD; van Puijvelde GH; Peterse N; de Vos P; van Weel V; van Wanrooij EJ; Biessen EA; Quax PH; Niethammer AG; Reisfeld RA; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2050-7. PubMed ID: 17600223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice.
    Petrovan RJ; Kaplan CD; Reisfeld RA; Curtiss LK
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1095-100. PubMed ID: 17303776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
    Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
    Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells.
    Eguchi M; Sekiya Y; Kikuchi Y; Takaya A; Yamamoto T; Matsui H
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):411-20. PubMed ID: 17573927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    Zhou JJ; Wang YM; Lee VWS; Zhang GY; Medbury H; Williams H; Wang Y; Tan TK; Harris DCH; Alexander SI; Durkan AM
    PLoS One; 2018; 13(4):e0195657. PubMed ID: 29641559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; Happé H; Hauer AD; de Vos P; Imanishi T; Fujiwara H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient mice.
    Sjöberg S; Eriksson EE; Tivesten A; Carlsson A; Klasson A; Levin M; Borén J; Krettek A
    Atherosclerosis; 2009 Oct; 206(2):369-74. PubMed ID: 19345948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
    Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
    Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
    Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.